Across tumor types, the expanding use of molecular profiling and biomarker analysis places increased demands on often limited amounts of tissue. As targeted therapies move into first-line settings, as the use of neoadjuvant therapy increase, and as biopsy size shrinks, optimized and comprehensive testing from small biopsy specimens is increasingly necessary. This session explores how recently released joint AMP and CAP guidelines regarding optimal tissue allocation and testing strategies can maximize the amount of information which can be gleaned from small tissue samples.
Optimal Assay Design for Small Specimens
Christopher Gilbert, DO, MS, Swedish Cancer Institute, Seattle, WA, USA
Best Practices for Tissue Allocation
Sinchita Roy-Chowdhuri, MD, PhD, The University of Texas MD Anderson, Houston, TX, USA
Objectives:
- Describe the role of the pathologist in triaging small specimens to maximize diagnostic utility
- Understand how appropriate assay design and selection can reduce tissue requirements for testing.
Recording Date: November 18, 2020
Continuing Education Credit Information
CME/CMLE credit: 1.00 hr
Last day to purchase course and CE claim credit: February 16, 2024
Note: Members of AMP can access this at a discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
